AstraZeneca's Symbicort Turbuhaler Reduces Asthma Attacks In New Trial
LONDON (Alliance News) - AstraZeneca PLC's Novel Start trial for its Symbicort Turbuhaler demonstrated a reduction in the rate of asthma attacks in patients with mild asthma compared to common Read More